oral glp-1 drugs A Pill to Fight Obesity Is on the Verge of Approval Oral GLP‑1 Therapy Type 2

Klaassen, Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver

Scutellarein alleviates chronic obstructive pulmonary disease through inhibition of ferroptosis by chelating iron and interacting with arachidonate 15-lipoxygenase

These therapies are still experimental and not yet ready for clinical practice, but they illustrate the importance of the concept of continuous dopaminergic stimulation in therapeutic research for PD

(2) reporting of clinical quality measures, including eCQMs

Lower risk of dementia A review of 14 studies published in 2018 in the Journal of Alzheimers Disease found that in six studies, diabetic subjects taking metformin had reduced the incidence of dementia by about 24 percent (6)